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Abstract: 
Influenza A virus is a serious public health threat. Most recently the 2009/H1N1 pandemic virus had an inherent ability to evade the host’s immune surveillance 
through genetic drift, shift, and genomic reassortment. Immune characterization of 2009/H1N1 utilized monoclonal antibodies, neutralizing sera, and proteomics. 
Increased age may have provided some degree of immunity, but vaccines against seasonal influenza viruses seldom yield cross-reactive immunity, exemplified by 
2009/H1N1. Nonetheless, about 33% of individuals, over the age of 60, had cross-reactive neutralizing antibodies against 2009/H1N1, whereas only 6-9% young 
adults had these antibodies. Children characteristically had no detectable immunity against 2009/H1N1. Taken together, these observations suggest some degree of 
immune transference with at least certain strains of virus that have afflicted the human population in past decades. Because internal influenza proteins may exhibit 
less antigenic variation, it is possible that prior exposure to diverse strains of influenza virus provide some immunity to novel strains, including the recent 
pandemic strain (swine-avian A/H1N1). Current trends in immunological studies – specifically the modulation of cellular immune surveillance provided by TH17 
and Tregs – also support the need for additional proteomic research for characterizing novel translational evidence-based treatment interventions based on cytokine 
function to help defeat the virus. Timely and critical research must characterize the impact of genetics and epigenetics of oral and systemic host immune 
surveillance responses to influenza A virus. The continued development and application of proteomics and gene expression across viral strains and human tissues 
increases our ability to combat the spread of influenza epidemics and pandemics. 
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Background & Description: 
The inherent ability of the 2009/H1N1 pandemic influenza virus to evade 
immune surveillance through genetic drift, shift, and genomic reassortment is a 
serious public health threat [1]. Reactivity studies demonstrate species-specific 
antigenic differences in virulence as well as immune surveillance. The 'avian-
like' swine viruses, including the recent pandemic strain (swine-avian A/H1N1) 
are characteristically most similar to avian viruses, and antigenic drift is more 
marked in 'avian-like' swine viruses than in classical swine strains [1].    
 
Humoral Immunity: 
Phage expression library molecular methods serve to characterize influenza 
antigens and antibodies. Immune characterization methods used whole-
genome-fragment phage display libraries expressing fragments of 15-350 
amino acids traversing all the proteins of influenza A/Vietnam/1203/2004 
(H5N1). These oligopeptides induced B cell responses using neutralizing sera 
and monoclonal antibodies following full recovery from H5N1 infection. This 
approach yielded two broadly neutralizing human monoclonal antibodies with 
conformation-dependent epitopes. Sera of patients convalescing from H5N1 
infection yielded potentially protective H5N1-specific antibody epitopes in the 
H5 HA, without any cross-reactivity with sera from H5N1-naïve or H1N1-
/H3N2-seropositive controls. Additional promising epitopes include the 
neuraminidase catalytic site M2 ectodomain, and the PB1-F2 virulence factor. 
The germline gene VH1-69 yields a common neutralizing mechanism specific 
for the HA fusion domain. This region exhibits less neutralization escape, and 
could be a promising strategy for broad-spectrum therapeutic protection against 
pandemic influenza threats [2].  
 
Cellular Immune Surveillance: 
A wider use of influenza vaccines could control the severity of influenza 
pandemics. Moreover, comparative effectiveness and efficacy research 
increasingly indicates that humoral immunity alone may be insufficient to 
defeat influenza virus. Cellular immune events, mediated by sub-populations of 
both CD4+ and CD8+ T lymphocytes, contribute important surveillance 
against influenza virus, via cytokine modulation and the cross-reactivity that 
exists with virus-specific cytotoxic T lymphocytes (CTL, CD8+CD38+). For 
epitopes on NP and M1, CTL-based assays cross-reacted with viral strains from BIOINFORMATION  open access 
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patient infections that were up to 9 years apart [3]. The 1977/8 influenza 
A/H1N1 infections occurred in otherwise healthy children and young adults in 
up to 50% of the cases. In fact, actuarial inferences from epidemiological data 
suggest that people infected with the 1945-55 influenza A/H1N1 developed 
immune surveillance against that later strain, which persisted as immune 
memory [4].  
 
Incidences for H5N1 infection and fatality rates are lower for the older than 40-
year age group (10.9% and 32%, respectively) than less than 40-year age group 
(89.1% and 59%, respectively). While these differences may be due to 
exposure to seasonal infection or vaccination, and the higher fatality rate may 
be due to differences in virus replication rates, the persistence of antigen-
specific CD8+ T cells confers the ability of CTL’s to clear infection and assists 
in reducing viral pathogenesis [5]. Greater than 97% of US H1N1 recovered 
isolates are from patients who are younger than 26 years old. For people over 
the age of 35, the recovery rate of H1N1 viruses drops to 4-5%. In the elderly, 
T-cell responses correlate better with vaccine protection than humoral 
immunity [6]. 
 
 
Figure 1: Tregs/TH17 Modulatory Balance in H1N1 Infection. (a) Cellular 
immune surveillance to H1N1 infection engages the release of a spectrum of 
cytokines (IFN-γ, TNF-α, IL015, IL-12p70, IL-8, IL-9, IL-6, IL-21, and TGF-
β) within the microenvironment [7, 11], which act in concert to regulate T cell 
subset activation, maturation and differentiation. TGF-β plays a critical role in 
the regulation of both TH17 and Tregs (CD4+CD25+FoxP3+), which blunt T 
cell activation and TH17 generation and activity. This dual signaling function 
of TGF-β suggests that the ultimate balance between these subsets in cellular 
immune surveillance to influenza is likely due to epigenetic factors in the 
microenvironment [11] such as consequential to, but not limited to pregnancy 
[12] and immune senescence [10]. (b) While the proportion of TH17 cells may 
be relatively low in influenza patients, compared to control subjects, the 
secretion of TH17 and TH1 cytokines is vigorous, and characteristically the 
reported cytokine “storms” [7]. (c) The cytokine “storms” cascade leads to an 
increase in CD8+CD38+ CTL’s, whose number and proportion correlate with 
the stage of infection, as they are responsible for the elimination of virally 
infected host cells. 
 
Viral infection leads to increased production of several cytokines, which are 
finely controlled by T cell sub-populations of TH17 and regulatory T cells 
(Tregs). The more virulent H5N1 influenza strain results in cytokine ‘storms’, 
characterized by sharp “great”-elevations of cytokine cascades [7]. IL-21, 
which is produced by TH17, may contribute to the mechanism by which CD4+ 
cells orchestrate the immune system response to viral infections, and 
specifically counteracts influenza infection in a mouse model. Without IL-21, 
CD4+ and CD8+ T cell responses are rapidly abrogated during acute and 
chronic viral infection, and viral clearance is severely impaired. IL-21 
stimulates activation and proliferation of natural killer cells and CTL’s via IL-
21 receptor-mediated activation of the STAT3 pathway [7, 8]. These 
modulatory effects by TH17 on one hand seem to be modulated by Tregs on 
the other, such that, for instance, IL-12 enhances anti-viral immune response, 
and the related cytokine, IL-28B (Type III anti-viral λFN family: with IFN-λ1, 
IFN-λ2, and IFN-λ3, e IL-29, IL-28A, and IL-28B, respectively) has substantial 
influence in adaptive immune responses as a vaccine adjuvant [9]. Presently, 
well-controlled experiments are used to characterize the cytokine storms in 
influenza pandemic, particularly in terms of TH17 and Tregs modulation. The 
current trends of knowledge depicted in Figure 1, opens novel avenues for 
clinical verification and Comparative Effectiveness and Efficacy Research and 
Analysis for (evidence-based) Practice (CEERAP), in order to utilize the best 
available evidence for ensuring most successful influenza management.  
 
Impact of Immunology on Clinical Outcome: 
In most cases, patients with H1N1 influenza have self-limited illness. However, 
some patients, especially those with co-morbidities, are more susceptible to 
influenza complications. In addition, the fine regulation of cellular immunity 
requires both vigorous effector responses and the maintenance of regulatory T 
subsets, such as TH17 and Tregs. Any disturbances in the balance between 
these two opposite activities of immune system, including tumor 
microenvironment, pregnancy or immune senescence, can seriously jeopardize 
this balance, and profoundly affects epigenetic regulatory controls of cellular 
immune surveillance [10-12]. The latter actually provides a suggestive 
rationale to account for the anomaly of the 2009 influenza pandemic that 
exhibited higher lethality in younger patients than in the elderly, as noted 
above, because it is conceivable that the Tregs/TH17 ratio may be biased 
toward Tregs with age, thus yielding to a suppression and inhibition of TH17-
mediated responses during senescence [10]. 
 
Pregnancy is a known risk of severe influenza. In the 2009 H1N1 pandemic, 
pregnancy led to increased risk of morbidity and mortality. In the US, most 
deaths in this population were due to pneumonia and respiratory failure. 
Because of the particular cellular immune conditions of pregnancy, vaccine 
failure is not uncommon in pregnant patients. To date, the corresponding 
efficacy of immune response to H1N1 monovalent vaccine remains unclear in 
this population. One mechanism may involve shifting immunity away from 
cell-medicated immunity towards humeral immunity, which could impair 
vaccine response. This may occur in association with occasional 
immunoglobulin G2 subclass deficiency in pregnant women with severe 
influenza. H1N1 may behave the same way in HIV infected population as in 
general population. Severe influenza seems to occur in late or advance 
diseases. Cellular immune response to the influenza virus appears to be lower 
in HIV-seropositive patients than general population.  
 
In conclusion, current trends suggest that immunological studies support the 
need for additional proteomic research for characterizing novel treatment 
interventions based on chemokine and cytokine functions to help defeat the 
influenza virus. Timely and critical research must characterize the impact of 
genetics and epigenetics of oral and systemic host immune surveillance 
responses to H1N1. The continued development and application of proteomics 
and gene expression to diagnosis and characterization of influenza viruses and 
host responses across viral strains and human tissues ensure our ability to 
combat the spread of influenza epidemics and pandemics by means of carefully 
articulated research synthesis designs for developing and testing Translational 
Comparative Effectiveness and Efficacy Research and Analysis for Practice (T-
CEERAP) interventions. 
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